PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 1-20 of 97

    August 23, 2019 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Turalio™ (pexidartinib)

    Daiichi Sankyo, Inc.

    August 01, 2019 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer, Inc.

    June 19, 2019 Drug Alert: Important Drug Warning

    Actemra® (tocilizumab)

    Genentech, Inc.

    May 17, 2019 Drug Alert: Important Drug Warning

    Jynarque™ (tolvaptan)

    Otsuka America Pharmaceutical Inc.

    April 01, 2019 Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks

    Analgesic Opioids

    Various

    March 29, 2019 Drug Alert: Important Drug Warning

    Arikayce® (amikacin liposome inhalation suspension)

    Insmed Incorporated

    March 04, 2019 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer, Inc.

    December 27, 2018 Drug Alert: Important Drug Warning

    Arikayce® (amikacin liposome inhalation suspension)

    Insmed Incorporated

    November 15, 2018 Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks

    Analgesic Opioids

    Various

    July 10, 2018 Drug Alert: FDA Required R.E.M.S. Safety Information

    Truvada

    Gilead Sciences, Inc.

    July 09, 2018 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    July 05, 2018 Drug Alert: Important Drug Information

    Xeljanz® (tofacitinib)

    Pfizer

    June 22, 2018 Drug Alert: Important Prescribing Information

    TECENTRIQ® (atezolizumab)

    Genentech, Inc.

    May 17, 2018 Drug Alert: Important Drug Warning

    Jynarque™ (tolvaptan)

    Otsuka America Pharmaceutical, Inc.

    February 16, 2018 Drug Alert: FDA Required Updated REMS Safety Information

    Zydelig® (idelalisib)

    Gilead Sciences, Inc.

    August 10, 2017 Drug Alert: Important Prescribing Information

    Humalog KwikPen®, 200 units/mL, (Humalog® U-200 KwikPen®)

    Lilly USA, LLC

    July 31, 2017 Drug Alert: Important Prescribing Information

    OPANA® ER (oxymorphone hydrochloride)

    Endo Pharmaceuticals Inc.

    July 07, 2017 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    July 03, 2017 Drug Alert: Important Drug Warning

    Tecentriq® (atezolizumab)

    Genentech, Inc.

    June 23, 2017 Drug Alert: Important Drug Warning

    Zelboraf® (vemurafenib)

    Genentech, Inc.

    Results 1-20 of 97